Robert Markovich
About Robert Markovich
Robert Markovich serves as the Senior Director of Analytical Development Research and Development at Nektar Therapeutics, a position he has held since 2013. He previously worked at Merck for 18 years in various roles, including Director of Analytical Sciences.
Current Role at Nektar Therapeutics
Robert Markovich serves as the Senior Director of Analytical Development Research and Development at Nektar Therapeutics. He has held this position since 2013, contributing to the company's efforts in advancing therapeutic innovations. His role involves overseeing analytical development processes and ensuring the quality and efficacy of pharmaceutical products. Nektar Therapeutics is located in South San Francisco, California.
Professional Experience at Merck
Prior to his current role, Robert Markovich worked at Merck for a total of 18 years. He began as a Principal Scientist from 1991 to 2003 in Kenilworth, New Jersey, where he focused on analytical sciences. He then advanced to the position of Director of Analytical Sciences from 2003 to 2009 in Union, New Jersey. His extensive experience at Merck contributed to significant advancements in analytical methodologies within the pharmaceutical industry.
Education and Expertise
Robert Markovich earned his Doctor of Philosophy degree from Purdue University, where he studied from 1986 to 1990. He also completed his Bachelor of Science degree at Purdue University from 1983 to 1986. Additionally, he attended the Illinois Institute of Technology for one year in 1982. His academic background provides a strong foundation in analytical development and research methodologies.
Academic Background at Purdue University
Markovich's academic journey at Purdue University is notable. He completed his Bachelor of Science degree from 1983 to 1986, followed by his Doctor of Philosophy from 1986 to 1990. He continued his studies at Purdue for an additional year from 1990 to 1991. This extensive education has equipped him with the knowledge and skills necessary for his roles in the pharmaceutical industry.